“Idorsia is a young company, it is no more than five years old but has a very long history behind it. We founded Actelion 25 years ago with the goal of innovation out of passion. It is the same goal we have now with Idorsia: we are counting on 450 people employed in the research of new drugs to make a difference in pathologies that still today have unmet needs “. Like this Martine ClozelExecutive Vice President and Chief Scientific Officer Idorsia, on the occasion of the launch of the Swiss company in Italy, on the occasion of the 16th edition of the World Sleep Congress which this year will be held at the Nuvola dell’Eur in Rome.
“In Italy and in other countries – added Clozel – we are developing working groups because we want not only to research but also to develop and market drugs. The one in Italy is one of Idorsia’s recent affiliations in European countries ”.